scispace - formally typeset
M

Melania Lo Iacono

Researcher at University of Palermo

Publications -  35
Citations -  1210

Melania Lo Iacono is an academic researcher from University of Palermo. The author has contributed to research in topics: Mesenchymal stem cell & Stem cell. The author has an hindex of 11, co-authored 28 publications receiving 981 citations.

Papers
More filters
Journal ArticleDOI

Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers

TL;DR: It is described for the first time that these cells, besides expressing all of the core-markers for mesenchymal stem cells, feature also the expression of tolerogenic molecules and markers of all the three main lineages, potentially important for both their differentiative potential as well as immunological features.
Journal ArticleDOI

New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity.

TL;DR: Data in the literature strongly suggest that WJ-MSC can differentiate into diverse cell types, showing a unique ability to cross lineage borders, and renders these cells extremely promising for regenerative medicine applications in different pathological settings.
Journal ArticleDOI

Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes

TL;DR: This review illustrates the recent advances made in differentiating human MSC to IPC, and compares the effectiveness of the differentiation protocols applied, the markers and functional assays used to characterize differentiated progeny, and the in vivo controls.
Journal ArticleDOI

Human Wharton's jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapy.

TL;DR: It is demonstrated for the first time that immune-related molecules which have been characterized in undifferentiated MSCs, are also expressed by the differentiated progeny, which strongly suggests that also after the acquisition of a mature phenotype, WJ-MSCs-derived cells may maintain their immune privilege.
Journal ArticleDOI

Umbilical cord revisited: From Wharton's jelly myofibroblasts to mesenchymal stem cells

TL;DR: UC structural features and the cell types which can be derived are described, with a focus on their phenotype and the novel results which boosted the use of UC-derived cells for regenerative medicine applications.